Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Orotidine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002738 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST002864 AN004696 Metabolic profiling, glucose tracing and glutamine tracing in naive and Enzalutamide-treated 16D prostate cancer cells expressing RFP or MYC Prostate cancer cells Human Cancer University of California, Los Angeles Abundance
ST002865 AN004697 Metabolic profiling, glucose tracing and glutamine tracing in 16D prostate cancer cells treated with vehicle, AR inhibitor Enzalutamide, AR inhibitor Apalutamide, or AR degrader/PROTAC ARCC-4 Prostate cancer cells Human Cancer University of California, Los Angeles Abundance
ST001447 AN002418 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Colon ICMS Intestine Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001453 AN002428 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Liver ICMS Liver Human Graft versus host disease University of Kentucky abundance & normalized peak area
ST001470 AN002446 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Lung ICMS Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001472 AN002448 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Small Intestines ICMS SI Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001986 AN003237 Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells T-cells Mouse University of Cambridge arbitrary unit
ST001902 AN003094 Metabolomics analysis of AsPC-1 PDAC cells treated with Porcupine inhibitor (LGK974) Cultured cells Human Cancer University of California, Los Angeles area
ST001143 AN001884 Microbial depletion and ozone exposure - Lung tissue (part I) Lung Mouse Asthma Harvard School of Public Health Area under curve
ST001144 AN001888 Microbial depletion and ozone exposure - serum (part II) Blood Mouse Asthma Harvard School of Public Health Area under curve
ST001639 AN002684 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST001850 AN002997 Unbiased LC-MS-based metabolomics analysis for both whole cell and mitochondria metabolites to gain an insight into the role of Tug1/PGC1 axis on metabolite profiles in podocytes Epithelial cells Mouse University of Texas MD Anderson Cancer Center AUC/ngDNA
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center estimated abundances
ST002555 AN004207 Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures Cultured cells Human Cancer University of Oklahoma Health Sciences Center Fold change over standard
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST001788 AN002900 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST002149 AN003519 In vivo commensal control of Clostridioides difficile virulence Cecum Mouse Brigham and Women’s Hospital Intensity
ST001188 AN001980 P. falciparum infected erythrocytes Cultured cells Plasmodium falciparum Malaria University of Melbourne ion count
ST001775 AN002882 Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi Blood Mouse Malaria Stanford University ion counts
ST002829 AN004622 Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study Blood Human COVID-19 National Institutes of Health log transformed data
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST002477 AN004046 Neutrophil metabolomics in COVID-19 Neutrophils Human COVID-19 UT Southwestern Medical Center MS reading
ST001474 AN004409 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Spleen ICMS Multiple tissues Mouse Graft versus host disease University of Kentucky natural abundance corrected and dry residue normalized peak area
ST002322 AN003789 Metabolomics study comparing SCAP KO and WT B cells Cultured cells Mouse Indiana University School of Medicine Normalized AUC
ST002216 AN003625 Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received metronidazole using high-resolution, high-performance LC-MS/MS analysis. Blood Mouse Cancer The Wistar Institute Normalized Peak Area
ST000497 AN000765 M-CMV infected Nicotiana tabacum Plant Tobacco Mosaic virus infection Chinese Academy of Inspection and Quarantine Normalized scale
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center osmolality normalized scaled imputed
ST002153 AN003526 Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 Blood Mouse Morinaga milk industry CO., LTD. peak area
ST002184 AN003577 Metabolic effect of the loss of mitochondrial-specific aspartyl-tRNA synthetase Das2 on mouse intestinal epithelial cells Intestine Mouse CECAD Research Center peak area
ST002205 AN003608 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Cultured cells Mouse Cancer CECAD Research Center, University Hospital Cologne peak area
ST002218 AN003627 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Part 2 Cultured cells Mouse Cancer CECAD Research Center peak area
ST002221 AN003630 Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002222 AN003631 Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002223 AN003632 Metabolic profiling of mouse tissues and tissue interstitial fluids Heart Mouse Cancer CECAD Research Center peak area
ST002223 AN003632 Metabolic profiling of mouse tissues and tissue interstitial fluids Kidney Mouse Cancer CECAD Research Center peak area
ST002223 AN003632 Metabolic profiling of mouse tissues and tissue interstitial fluids Liver Mouse Cancer CECAD Research Center peak area
ST002223 AN003632 Metabolic profiling of mouse tissues and tissue interstitial fluids Lung Mouse Cancer CECAD Research Center peak area
ST002224 AN003633 Intracellular metabolic profile of renal cells cultured in Plasmax Cultured cells Human Cancer CECAD Research Center peak area
ST002498 AN004657 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST002736 AN004438 Assessing mitochondrial bioenergetics in coronary artery disease: A translational multiomic tissue study in humans (The AMBITION study). Heart Human Cardiovascular disease Imperial College London peak area
ST001157 AN001915 The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) Blood Mouse Johns Hopkins University School of Medicine Peak area
ST001158 AN001916 The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) Feces Mouse Johns Hopkins University School of Medicine Peak area
ST001212 AN002047 Fish-oil supplementation in pregnancy, child metabolomics and asthma risk Blood Human Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen Peak area
ST001218 AN002031 Wild type versus TRACK Mice on regular chow and Vitamin A deprived diet Kidney Mouse Cancer weill cornell medicine Peak area
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan Peak area
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan Peak area
ST001658 AN002707 Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites Yeast cells Yeast Cancer Johns Hopkins University Peak area
ST001658 AN002709 Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites Yeast cells Yeast Cancer Johns Hopkins University Peak area
ST002492 AN004084 Composition of raw plant-based food items Plant Plants Northeastern University Peak area
ST002754 AN004471 Metabolomics analysis of maternal obesity model Blood Mouse Fatty liver disease University of Bonn Peak Area
ST002909 AN004778 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Peak Area
ST001170 AN001935 Timecourse on MCF-7 cells treated with different concentration of doxorubicin Cultured cells Human China Pharmaceutical University Peak area normalized
ST002066 AN003366 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer The Walter and Eliza Hall Institute of Medical Research peak height
ST002412 AN003932 Metabolic effects of the protein kinase R Macrophages Mouse Hudson peak height
ST002792 AN004543 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University peak height
ST002926 AN004799 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University peak height
ST000403 AN000643 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000414 AN000656 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000819 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000546 AN000833 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University Peak height
ST001201 AN001999 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001201 AN001999 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001547 AN002577 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University Peak intensity
ST001549 AN002581 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST000451 AN000707 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data Muscle Mouse University of North Carolina Peak values (scaled)
ST000452 AN000708 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data Blood Mouse University of North Carolina Peak values (scaled)
ST001745 AN002841 Metabolomic profiling of the rat hippocampus across developmental ages and after learning Brain Rat New York University pmoles/l
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai pmoles/l
ST001983 AN003234 Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines Ovarian cancer cells Human Cancer University of Oklahoma Health Sciences Center ratio
ST001835 AN002977 Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes Blood Human Idaho Veterans Research and Education Foundation raw area count
ST000899 AN001465 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST001400 AN002342 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria Blood Human Malaria New York University Abu Dhabi raw area counts
ST001516 AN002517 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001517 AN002520 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001749 AN002851 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002818 AN004589 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002819 AN004593 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004597 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002090 AN003414 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) Feces Mouse Irritable bowel syndrome Mayo Clinic raw intensity
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center Relative Abundance
ST002106 AN003445 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002107 AN003447 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002108 AN003449 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002088 AN003409 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003413 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST001869 AN003031 WNK463 Inhibition on Right Ventricular metabolomics Heart Rat Hypertension University of Minnesota relative value
ST001870 AN003032 Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats Heart Rat University of Minnesota relative value
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST000930 AN001524 Define alterations in the gut metabolome of mice infected with C. difficile Intestine Mouse North Carolina State University scaled intensity
ST001515 AN002514 A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans Blood Human Obesity Translational Research Institute- AdventHealth Orlando scaled units
ST001175 AN001951 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University Signal Intensity
ST001304 AN002173 Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii Fibroblast cells Toxoplasma gondii Parasitic infection Monash University Signal Intensity
ST001253 AN002082 Phenotyping Mouse blood metabolites in day and night in type 2 diabetes Blood Mouse Diabetes Indiana University School of Medicine VolNormImp Area counts
  logo